D. Krag

D. Weaver, D. Krag, S. Harlow, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Minimal access surgery for staging regional lymph nodes: the sentinel-node concept.

D. Krag, 1998, Current problems in surgery.

Why perform randomized clinical trials for sentinel node surgery for breast cancer?

D. Krag, 2001, American journal of surgery.

In Vitro and in Vivo Cytotoxicity of Rhodamine 123 Combined with Hyperthermia 1

D. Krag, F. K. Storm, J. Wong, 2006 .

Hyperthermic enhancement of rhodamine 123 cytotoxicity in B16 mouse melanoma cells in vitro.

D. Krag, A. Théon, L. Gan, 1990, Cancer research.

Reversal of thermochemotherapeutic resistance to rhodamine 123 by verapamil.

D. Krag, A. Théon, L. Gan, 1990, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Relationship between cellular accumulation of rhodamine 123 (R123) and cytotoxicity in B16 melanoma cells.

D. Krag, A. Théon, L. Gan, 1989, The Journal of surgical research.

Breast Cancer Survival According to Number of Nodes Removed

D. Krag, R. Single, 2003, Annals of Surgical Oncology.

Induction of transient hyperglycaemia in cancer patients.

D. Krag, D. Morton, F. K. Storm, 1990, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?

M. Ross, D. Krag, J. Gershenwald, 2001, Annals of Surgical Oncology.

Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.

T. Julian, J. Skelly, N. Wolmark, 2009, Journal of the National Cancer Institute.

Characterization of sentinel node-derived antibodies from breast cancer patients.

D. Krag, S. Harlow, S. Pero, 2018, Journal of immunological methods.

Sentinel lymph node biopsy for the detection of metastases.

D. Krag, 2000, Cancer journal.

Guidelines for the Safe Use of Radioactive Materials During Localization and Resection of the Sentinel Lymph Node

P. Flicek, D. Krag, C. Shriver, 1999, Annals of Surgical Oncology.

Submission of lymph node tissue for ancillary studies decreases the accuracy of conventional breast cancer axillary node staging.

D. Weaver, D. Krag, S. Harlow, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Breast Cancer and Internal Mammary Sentinel Nodes

D. Krag, T. Ashikaga, R. Olmos, 2014 .

Preoperative technetium Tc 99m sestamibi imaging. Paving the way to minimal-access parathyroid surgery.

R. Foster, M. Nathan, D. Krag, 1996, Archives of otolaryngology--head & neck surgery.

Sentinel lymph node biopsy for staging breast cancer.

D. Krag, S. Korourian, I. Rubio, 1998, American journal of surgery.

Sentinel Lymph Node Biopsy for Breast Cancer: The Role of Previous Biopsy on Patient Eligibility

D. Krag, C. Shriver, M. Maniscalco-Theberge, 1999, The American surgeon.

The design of trials comparing sentinel-node surgery and axillary resection.

D. Krag, T. Ashikaga, 2003, The New England journal of medicine.

Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients

D. Chen, D. Krag, A. Kapelner, 2013, Journal of Translational Medicine.

Effect of occult metastases on survival in node-negative breast cancer.

Donald L. Weaver, Stewart J. Anderson, David N. Krag, 2011, The New England journal of medicine.

Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study

M. Gadd, D. Weaver, D. Krag, 2001, Melanoma research.

Axillary Metastases with Unknown Primary

D. Krag, T. James, 2010 .

Radioguided Sentinel Lymph Node Mapping and Biopsy in Non-small Cell Lung Cancer (NSCLC)

D. Krag, R. Sadeghi, L. Zarifmahmoudi, 2016 .

Abstract S2-05: 10-yr follow-up results of occult detected sentinel node disease: NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients

T. Julian, J. Costantino, N. Wolmark, 2013 .

Cytokeratin-positive Cells in the Bone Marrow of Breast Cancer Patients and Noncancer Donors

D. Weaver, D. Krag, E. Manna, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

The Detection of Isolated Tumor Cells in Bone Marrow Comparing Bright-Field Immunocytochemistry and Multicolor Immunofluorescence

D. Weaver, D. Krag, E. Manna, 2005, Annals of Surgical Oncology.

Phage-displayed random peptide libraries in mice: toxicity after serial panning

D. Weaver, D. Krag, Chen Liu, 2002, Cancer Chemotherapy and Pharmacology.

Design and synthesis of paclitaxel conjugated with an ErbB2-recognizing peptide, EC-1.

D. Krag, P. Roller, P. Li, 2007, Biopolymers.

Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer

D. Krag, C. Shriver, M. Maniscalco-Theberge, 1998, Annals of Surgical Oncology.

Practice patterns of sentinel node biopsy at five comprehensive cancer centers.

T. Julian, D. Krag, 2003, Journal of the National Cancer Institute.

Sentinel lymph node--why study it: implications of the B-32 study.

D. Krag, S. Harlow, 2001, Seminars in surgical oncology.

Sentinel node biopsy for breast cancer: showtime or dress rehearsal?

D. Krag, T. Ashikaga, F. Moffat, 2000, In vivo.

Sentinel nodes: clinical trial data needed.

D. Krag, J. Abrams, T. Ashikaga, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients.

T. Julian, J. Costantino, N. Wolmark, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

10-yr follow-up results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients.

T. Julian, J. Costantino, N. Wolmark, 2010 .

A simplified technique to resect abnormal bony radiolocalizations using a gamma counter.

P. Schneider, D. Krag, J. Goodnight, 1992, Surgical oncology.

Tamoxifen and Cardiac Risk Factors in Healthy Women Suggestion of an Anti-inflammatory Effect

John D. Roberts, J. Costantino, D. Krag, 2001 .

Tamoxifen and Cardiac Risk Factors in Healthy Women: Suggestion of an Anti-inflammatory Effect

John D. Roberts, J. Costantino, D. Krag, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Breast Cancer Cells in the Blood: A Pilot Study

D. Weaver, D. Krag, S. Harlow, 1999, The breast journal.

A cocktail of antibodies to multiple tumor-specific neoantigens increases binding and inhibits tumor growth

D. Krag, S. Pero, G. Shukla, 2019 .

Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7*

D. Krag, P. Roller, R. Daly, 2002, The Journal of Biological Chemistry.

Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer

D. Krag, I. Rubio, V. Klimberg, 1998, Annals of Surgical Oncology.

Clinical Assessment of 111In-CYT-103 Immunoscintigraphy in Ovarian Cancer

D. Krag, S. Waggoner, H. Gallion, 1993 .

Vaccine draining lymph nodes are a source of antigen-specific B cells.

D. Krag, C. Teuscher, D. Krementsov, 2017, Vaccine.

Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial

John D. Roberts, J. Costantino, D. Wickerham, 2003, British journal of haematology.

Phage display selection for cell-specific ligands: Development of a screening procedure suitable for small tumor specimens

D. Krag, G. Shukla, 2005, Journal of drug targeting.

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

D. Krag, S. Harwood, E. Mitchell, 1992, Radiology.

Radiolabeled Antibody Imaging in the Management of Colorectal Cancer Results of a Multicenter Clinical Study

D. Krag, E. Mitchell, R. Doerr, 1991, Annals of surgery.

Intralesional cis‐diamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: A feasibility study

P. Schneider, D. Krag, J. Goodnight, 1990, Journal of surgical oncology.

Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.

D. Krag, Matthew C.J. Wilce, M. Gunzburg, 2011, Journal of molecular biology.

Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?

D. Krag, G. Treglia, R. Sadeghi, 2014, Breast Cancer Research and Treatment.

Phage-display selection on tumor histological specimens with laser capture microdissection.

D. Weaver, D. Krag, S. Pero, 2009, Journal of immunological methods.

Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature

D. Krag, R. Sadeghi, S. Tehranian, 2014, Surgery Today.

Gamma probe localization of cranial bone lesions.

D. Krag, D. Weinberg, G. D. Albert, 1999, Ophthalmic plastic and reconstructive surgery.

Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.

P. Schneider, J. Bushberg, D. Krag, 1993, Archives of surgery.

Development of Sentinel Node Targeting Technique in Breast Cancer Patients

D. Weaver, D. Krag, S. Harlow, 1998 .

Diversification and shared features of tumor‐binding antibody repertoires in tumor, sentinel lymph node and blood of three patients with breast cancer

Aaron M. Rosenfeld, D. Krag, S. Harlow, 2022, Clinical & Translational Immunology.

Internal mammary sentinel lymph node biopsy in clinical practice.

D. Krag, M. Asadi, 2016, International journal of surgery.

Is axillary dissection needed when the sentinal node is positive? Yes!

D. Krag, 2008, Journal of surgical oncology.

Breast cancer and the NSABP-B32 sentinel node trial

T. Julian, D. Krag, S. Harlow, 2004, Breast cancer.

The sentinel node in breast cancer

M. Gadd, D. Weaver, D. Krag, 1999 .

Current status of axillary lymph node dissection and sentinel node biopsy in breast cancer.

D. Krag, 2010, Clinical advances in hematology & oncology : H&O.

Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells

D. Weaver, D. Krag, J. Bond, 2004, International journal of cancer.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

T. Julian, J. Kopec, J. Costantino, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies

D. Krag, C. Slingluff, W. Olson, 2017, Journal of Translational Medicine.

Sentinel-lymph-node biopsy [1] (multiple letters)

M. Ross, D. Krag, O. Schillaci, 1999 .

Psychological adjustment in breast cancer: processes of emotional distress.

J. Epping-Jordan, D. Krag, C. Gerhardt, 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Composite tissue transfer in limb-salvage surgery.

P. Schneider, D. Krag, J. Goodnight, 1991, Archives of Surgery.

Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain*

D. Krag, Shaomeng Wang, P. Roller, 1997, The Journal of Biological Chemistry.

Intratumoral chemotherapy with cisplatin in oily emulsion in horses.

D. Krag, G. Carlson, J R Pascoe, 1993, Journal of the American Veterinary Medical Association.

Sentinel Lymph Node Radiolocalization in Head and Neck Squamous Cell Carcinoma

D. Krag, B. Wenig, C. Sasaki, 2000, The Laryngoscope.

Gamma-probe-guided lymph node localization in malignant melanoma.

D. Weaver, D. Krag, J C Alex, 1993, Surgical oncology.

The gamma-probe-guided resection of radiolabeled primary lymph nodes.

D. Krag, J C Alex, D N Krag, 1996, Surgical oncology clinics of North America.

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.

D. Weaver, D. Krag, J C Alex, 1993, Surgical oncology.

Minimal-access surgery for staging of malignant melanoma.

D. Weaver, D. Krag, S. Harlow, 1995, Archives of surgery.

Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: A clinical analysis of seven cases

D. Krag, D N Krag, M S Brady, 1998, Journal of surgical oncology.

Sentinel lymph node biopsy for breast cancer

D. Krag, S. Ueda, T. Shigekawa, 2007, Journal of surgical oncology.

A cocktail of polyclonal affinity enriched antibodies against melanoma mutations increases binding and inhibits tumor growth.

D. Krag, S. Pero, G. Shukla, 2019, Journal of immunological methods.

Selection of tumor-binding ligands in cancer patients with phage display libraries.

Donald L Weaver, Guang-Ping Shen, Stephanie Pero, 2006, Cancer research.

Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.

D. Krag, G. Sholler, S. Pero, 2018, Journal of immunological methods.

Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node

Jonathan R. McDaniel, D. Krag, S. Harlow, 2017, bioRxiv.

Interaction of the non‐phosphorylated peptide G7‐18NATE with Grb7‐SH2 domain requires phosphate for enhanced affinity and specificity

D. Krag, M. Gunzburg, J. Wilce, 2012, Journal of molecular recognition : JMR.

Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells

D. Krag, S. Flemer, S. Pero, 2007, British Journal of Cancer.

Autologous antibodies that bind neuroblastoma cells.

D. Krag, G. Sholler, S. Pero, 2015, Journal of immunological methods.

Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer

D. Krag, T. Ashikaga, Leah J. Novinger, 2014, Cancer Immunology, Immunotherapy.

Gamma-probe guided localization of lymph nodes.

D. Krag, J C Alex, D N Krag, 1993, Surgical oncology.

Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma

D. Weaver, D. Krag, S. Harlow, 2000, Cancer.

The sentinel node for staging breast cancer: Current review

David N. Krag, D. Krag, 1999, Breast cancer.

Popliteal cyst producing complete arterial occlusion. A case report.

D. Krag, H. Stansel, 1982, The Journal of bone and joint surgery. American volume.

Laryngeal Mask Airway

D. Krag, R. Sofferman, D. L. Johnson, 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

GRB7 is required for triple-negative breast cancer cell invasion and survival

D. Krag, J. Sparano, P. Kenny, 2012, Breast Cancer Research and Treatment.

Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe?

P. Schneider, D. Krag, J. Goodnight, 1993, Archives of surgery.

First Clinical Report

Robert D. Howe, Parris S. Wellman, David N. Krag, 2015 .

Effect of localized magnetic‐induction hyperthermia on the brain. Temperature versus intracranial pressure

D. Krag, D. Morton, A. Silberman, 1986, Cancer.

Sentinel lymph node biopsy for melanoma.

D. Krag, J. Kuhn, J. Preskitt, 1998, American journal of surgery.

Breast cancer metastasis through the lympho-vascular system

H. Kuerer, L. Newman, D. Krag, 2018, Clinical & Experimental Metastasis.

The Augsburg consensus

D. Krag, A. Cochran, D. Morton, 2000, Cancer.

Highly Selective Tumor Targeting With Phage Display and Laser Capture Microdissection

D. Krag, Yu-jing Sun, 2010 .

Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies

D. Krag, L. McCahill, S. Pero, 2013, Cancer Immunology, Immunotherapy.

UNCLASSIFIED AD NUMBER ADB 232 935 NEW LIMITATION CHANGE

D. Krag, 2022 .

Differential expression of Oct3/4 in human breast cancer and normal tissues.

D. Weaver, D. Krag, F. Zhao, 2018, International journal of oncology.

Pathological and molecular assessment of sentinel lymph nodes in solid tumors.

D. Weaver, D. Krag, 2002, Seminars in oncology.

Selective delivery of therapeutic agents for the diagnosis and treatment of cancer

D. Krag, G. Shukla, 2006, Expert opinion on biological therapy.

Unfiltered Sulfur Colloid and Sentinel Node Biopsy for Breast Cancer: Technical and Kinetic Considerations

D. Krag, G. Sfakianakis, A. Livingstone, 1999, Annals of Surgical Oncology.

Localized thermo-cisplatin therapy: a pilot study in spontaneous canine and feline tumours.

D. Krag, B. Madewell, A. Moore, 1991, International Journal of Hyperthermia.

Breast cancer metastasis through the lympho-vascular system

H. Kuerer, L. Newman, D. Krag, 2018, Clinical & Experimental Metastasis.

Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma.

D. Weaver, D. Krag, S. Harlow, 1999, Journal of the American College of Surgeons.

The False-Negative Rate of Sentinel Node Biopsy in Patients with Breast Cancer: A Meta-Analysis

D. Krag, T. Ashikaga, S. Pesek, 2012, World Journal of Surgery.

Sentinel lymph node localization in early breast cancer.

R G Carroll, D. Krag, G. Sfakianakis, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sentinel node biopsy: historical aspects

D. Krag, R. Uren, 2003 .

Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.

D. Weaver, D. Krag, S. Feldman, 1999, Journal of the American College of Surgeons.

Thermal resistance of human malignant melanoma modulated by prostaglandin E2

D. Krag, D. Morton, F. K. Storm, 1988, Journal of surgical oncology.

Sentinel node mapping in anal canal cancer: systematic review and meta-analysis.

D. Krag, G. Treglia, R. Sadeghi, 2013, Journal of gastrointestinal and liver diseases : JGLD.

In Vitro and in Vivo Cytotoxicity of Rhodamine 123 Combined with Hyperthermia1

D. Krag, F. K. Storm, J. Wong, 2006 .

Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision

D. Krag, S. Harlow, H. Evans, 2003, Annals of Surgical Oncology.

Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models

D. Krag, G. Sholler, F. Zhang, 2019, Clinical and Translational Oncology.

Nuclear medicine and the surgeon

D. Krag, F. Moffat, 1999, The Lancet.

Localization of regional lymph nodes in melanomas of the head and neck.

D. Weaver, D. Krag, S. Harlow, 1998, Archives of otolaryngology--head & neck surgery.

Internal Mammary Sentinel N odes

D. Krag, T. Ashikaga, R. Olmos, 2014 .

Targeting of palpable B16-F10 melanoma tumors with polyclonal antibodies on white blood cells.

D. Krag, S. Pero, G. Shukla, 2022, Journal of immunological methods.

Extra-axillary sentinel lymph nodes in breast cancer

D. Weaver, D. Krag, T. Ashikaga, 1999, Breast cancer.

Development of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.

D. Krag, G. Sholler, S. Pero, 2022, Annals of clinical and laboratory science.

Menachem J. GunzburgNigus D. AmbayeJack T. Hertzog • Mark P. Del BorgoStephanie C. PeroDavid N. KragMatthew C. J. Wilce • Marie-Isabel AguilarPatrick PerlmutterJacqueline A. Wilce

D. Krag, S. Pero, 2010 .

Optimal particle size of radiocolloid for sentinel node identification in breast cancer — Electron microscopic study and clinical comparison

S. Kosuda, D. Krag, H. Tsuda, 2004, Breast cancer.

Cancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries.

D. Krag, G. Shukla, 2010, Protein engineering, design & selection : PEDS.

Novel β-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy

D. Krag, David N Krag, Girja S Shukla, 2009, Journal of drug targeting.

Developing bifunctional β‐lactamase molecules with built‐in target‐recognizing module for prodrug therapy: identification of Enterobacter Cloacae P99 cephalosporinase loops suitable for randomization and phage‐display selection

D. Krag, G. Shukla, 2009, Journal of molecular recognition : JMR.

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

D. Krag, E. Manna, M. Herrler, 2008, Breast Cancer Research.

Bmc Structural Biology Grb7 Sh2 Domain Structure and Interactions with a Cyclic Peptide Inhibitor of Cancer Cell Migration and Proliferation

Joel P Mackay, Corrine J Porter, Edu, 2022 .

Calorimetric investigation of phosphorylated and non‐phosphorylated peptide ligand binding to the human Grb7‐SH2 domain

D. Krag, P. Roller, A. Spuches, 2007, Journal of molecular recognition : JMR.

Towards a ligand targeted enzyme prodrug therapy: Single round panning of a β‐lactamase scaffold library on human cancer cells

C. J. Murray, D. Krag, V. Schellenberger, 2007, International journal of cancer.

Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.

T. Julian, J. Kopec, N. Wolmark, 2012, The journal of supportive oncology.

Sentinel lymph node B cells can predict disease-free survival in breast cancer patients

D. Krag, K. Blenman, P. Frankel, 2018, npj Breast Cancer.

Intraoperative Ultrasound Versus Mammographic Needle Localization for Ductal Carcinoma In Situ

D. Krag, S. Harlow, T. James, 2009, Annals of Surgical Oncology.

Grb7-based molecular therapeutics in cancer

D. Krag, R. Daly, S. Pero, 2003, Expert Reviews in Molecular Medicine.

Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer

T. Julian, D. Weaver, D. Krag, 2005, Annals of surgery.

Axillary Lymph Node Dissection

D. Krag, T. James, Ted A. James, 2010 .

Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons.

D. Krag, S. Harlow, T. James, 2009, Archives of surgery.

Gamma probe location of 111 indium‐labeled B72.3: An extension of immunoscintigraphy

P. Schneider, D. Krag, P. Ford, 1992, Journal of surgical oncology.

Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

D. Krag, M. Mori, S. Arii, 2006, Journal of the National Cancer Institute.

Adjustment to breast cancer: age‐related differences in coping and emotional distress

J. Epping-Jordan, D. Krag, B. Compas, 1999, Breast Cancer Research and Treatment.

NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial

Donald L. Weaver, Richard M. Single, David N. Krag, 2004, Annals of Surgical Oncology.

Intrusive thoughts and avoidance in breast cancer: Individual differences and association with psychological distress

D. C. Howell, D. Krag, B. Compas, 2000, Psychology & health.

Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer

T. Julian, D. Weaver, D. Krag, 2006, Cancer.

Current status of sentinel node surgery in breast cancer.

D. Krag, S. Harlow, 2003, Oncology.

Breast Cancer Prognostication by Pathologic Node Staging (pN-staging) System Versus Lymph Node Ratio (LNR): A Critical Review of Conflicts With Number of Nodes, Z-0011 Trial , Staging Cut-points, Neo-adjuvant Therapy, and Survival Estimation

D. Krag, A. Kaviani, A. Safavi, 2017 .

Peptide Ligand for Grb 7 Signal Transduction Protein and Pancreatic Cancer Metastasis

D. Krag, M. Mori, S. Arii, 2006 .

Metastasis Detection in Sentinel Lymph Nodes: Comparison of a Limited Widely Spaced (NSABP Protocol B-32) and a Comprehensive Narrowly Spaced Paraffin Block Sectioning Strategy

D. Weaver, D. Krag, S. Harlow, 2009, The American journal of surgical pathology.

Gamma probe guided sentinel node biopsy in breast cancer.

R G Carroll, D. Krag, S. Gulec, 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Clinical utility of immunoscintigraphy in managing ovarian cancer.

D. Krag, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vitro and in vivo cytotoxicity of rhodamine 123 combined with hyperthermia.

D. Krag, F. K. Storm, J. Wong, 1990, Cancer research.

Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library.

D. Krag, David N Krag, Girja S Shukla, 2005, Oncology reports.

Transport and retention of colloidal tracers in regional lymphoscintigraphy in melanoma: influence on lymphatic mapping and sentinel node biopsy

O. Hoekstra, D. Krag, R. Pijpers, 1998, Melanoma research.

Sentinel lymph node B cells can predict disease-free survival in breast cancer patients

D. Krag, K. Blenman, P. Frankel, 2018, npj Breast Cancer.

A Sensitive and Rapid Chemiluminescence ELISA for Filamentous Bacteriophages

D. Krag, G. Shukla, 2005, Journal of immunoassay & immunochemistry.